|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-4-4
|
|
pubmed:abstractText |
To determine if the procatabolic activity of inflammatory synovial fluids (SF) from patients with rheumatoid arthritis (RA) could be attenuated by the cytokine antagonists murine leukemia inhibitory factor (LIF) binding protein (mLBP) and interleukin 1 receptor antagonist (IL-1ra).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
332-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10685793-Animals,
pubmed-meshheading:10685793-Arthritis, Rheumatoid,
pubmed-meshheading:10685793-Cartilage,
pubmed-meshheading:10685793-Cells, Cultured,
pubmed-meshheading:10685793-Chondrocytes,
pubmed-meshheading:10685793-Growth Inhibitors,
pubmed-meshheading:10685793-Humans,
pubmed-meshheading:10685793-Interleukin-6,
pubmed-meshheading:10685793-Leukemia Inhibitory Factor,
pubmed-meshheading:10685793-Lymphokines,
pubmed-meshheading:10685793-Osteoarthritis,
pubmed-meshheading:10685793-Proteoglycans,
pubmed-meshheading:10685793-Swine,
pubmed-meshheading:10685793-Synovial Fluid
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
|
|
pubmed:affiliation |
Department of Rheumatology and the Research Centre, Royal Perth Hospital, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
